Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico study
Authors (first, second and last of 10)
In Silico Pharmacology provides a forum for research articles at the cross-roads of computation, pharmacology, toxicology and pharmaceutics, and is relevant to all areas of basic science and therapeutics. Within this context, neuroscience and drug discovery are areas of special interest to the journal, as are state-of-the-art multiscale modelling, informatics, artificial intelligence, and big data.
Journal information
- Editor-in-Chief
-
- Boris Gutkin,
- Pramod Nair,
- Defang Ouyang,
- Chang-Guo Zhan
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 34 days
- Submission to first decision
- 164 days
- Submission to acceptance
- 12,761 (2019)
- Downloads
Latest issue
Latest articles
-
-
In silico analysis of STX2a-PE15-P4A8 chimeric protein as a novel immunotoxin for cancer therapy
Authors (first, second and last of 5)
-
-
Computational insight into the protective mechanism of Allium iranicum Wendelbo. Alliaceae in a mouse model of Staphylococcosis: focus on dietary phytocannabinoid trans-caryophyllene
Authors (first, second and last of 4)
-
About this journal
- Electronic ISSN
- 2193-9616
- Abstracted and indexed in
-
- BIOSIS
- CNKI
- Dimensions
- EBSCO Academic Search
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Advanced Technologies & Aerospace Database
- ProQuest Central
- ProQuest Computer Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Reaxys
- TD Net Discovery Service
- Copyright information
